Intraindividual CVs of plasma insulin concentrations and GIRs in the four studies
| FIRI_AUC(0–end of study) | GIR_AUC(0–end of study) | |
|---|---|---|
| Studies R+, R- horizontal, R- up, R- down | 16 (14–19) | 45 (38–53) |
| Studies R+, R- horizontal | 14 (8–21) | 62 (51–73) |
| Studies R+, R- up | 20 (11–29) | 54 (45–64) |
| Studies R+, R- down | 23 (13–34) | 48 (40–56) |
| FIRI Tmax | GIR Tmax | |
| Studies R+, R- horizontal, R- up, R- down | 63 (52–75) | 9 (8–10) |
| Studies R+, R- horizontal | 39 (33–46) | 7 (6–8) |
| Studies R+, R- up | 68 (56–81) | 10 (8–11) |
| Studies R+, R- down | 47 (40–55) | 9 (8–11) |
| FIRI Cmax | FIRI Tmax | |
| Studies R+, R- horizontal, R- up, R- down | 18 (16–21) | 28 (24–33) |
| Studies R+, R- horizontal | 20 (17–23) | 29 (16–44) |
| Studies R+, R- up | 20 (17–23) | 30 (16–44) |
| Studies R+, R- down | 28 (24–33) | 31 (17–47) |
Data are mean (95% CI).